Category: Cardiac Assist Devices
Doctors in Paraguay demonstrate the 1st human use of Thoratec's HeartMate PHP catheter-based heart pump in stabilizing a patient amid a percutaneous coronary procedure.
Thoratec (NSDQ:THOR) touted the 1st human use of its HeartMate PHP device as a "milestone case" for the heart pump technology.
Dr. Adrian Ebner at Sanatorio Italiano in Asuncion, Paraguay, used HeartMate PHP to stabilize a patient for an hour on the operating table during a percutaneous coronary procedure. Two other patients were subsequently treated with the catheter-based heart pump.
Abiomed says a quartet of private health insurers expanded their reimbursement policies for its flagship Impella heart pump.
Abiomed (NSDQ:ABMD) won expanded reimbursement for its flagship Impella heart pump from 4 private and Medicare Advantage insurers, including 1 of the largest names in the industry.
Humana, UnitedHealthcare Medicare Risk, Independence Blue Cross and Capital Blue Cross. The expanded coverage at the private or Medicare Advantage plans includes new Impella policies.
Mayo Clinic researchers examine the interaction between implantable cardiac devices and the electromagnetic interference generated by hybrid-electric vehicles, finding no reason for concern.
In the 1st study of its kind to examine the interaction between hybrid cars and implantable cardiac devices, researchers found that the electromagnetic waves generated by the green vehicles don't pose a threat.
"Hybrid cards do not generated clinically relevant amounts of [electromagnetic interference]," according to a team of researchers from the Mayo Clinic of Arizona. "It is safe for patients with ICD to interact with hybrid cars."
Sales for medical device company HeartWare surged during the 4th quarter and 2012 after the FDA gave the green light to its implanted heart pump last November.
Sales of its implantable heart pump surged during the 4th quarter and 2012 for HeartWare International (NSDQ:HTWR) after the medical device company won FDA approval for its flagship left ventricular assist device late last year.
Abiomed shares start strong today after the medical device company says the FDA closed out a 2011 warning letter over its marketing of the Impella heart pump.
Abiomed (NSDQ:ABMD) shares opened up today and rose some 3% this morning after the medical device company said late yesterday that the FDA closed out a 2011 warning over the marketing of its Impella heart pump.
Medical device giant Medtronic lands FDA approval for its MRI-friendly Advisa pacemaker system.
Medical device giant Medtronic (NYSE:MDT) won FDA approval for its Advisa DR MRI SureScan pacing system, planning to launch commercial efforts immediately.
The pacemaker's SureScan technology allows patients to receive MRI scans that normally pose a threat to traditional pacemaker function and patient safety.
Vatican officials unveil that outgoing Pope Benedict has had a pacemaker for years and that he recently underwent a routine battery replacement.
Vatican officials revealed today that Pope Benedict has had a pacemaker for years, and recently underwent surgery to replace the implant's battery.
Vatican spokesman Rev. Federico Lombardi told reporters that the outgoing Pope had his pacemaker for "a long time" prior to being named Pope in 2005.